Access cutting-edge alzheimer's disease treatment through this clinical trial at a research site in Anaheim. Study-provided care at no cost to qualified participants.
Access alzheimer's disease specialists in Anaheim at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alzheimer's disease treatment provided free
This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies in patients with ADP * Substudy 1 (Phase 2) will evaluate efficacy and dose response of ACP-204 30 and 60 mg vs placebo. This substudy will be initiated first. * Substudies 2A and 2B (both: Phase 3) will be confirmatory studies of either both doses (ACP-204 30 and 60 mg, respectively) or a single dose from Part 1 vs placebo. Substudies 2A and 2B wi
Sponsor: ACADIA Pharmaceuticals Inc.
Check if you qualify for this alzheimer's disease clinical trial in Anaheim, CA
If you're searching for alzheimer's disease treatment options in Anaheim, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Anaheim research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alzheimer's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.